A new study from researchers at Wake Forest University School of Medicine shows that only 3.5 years of intensive blood ...
In a small cohort of adults in South Korea, the presence of cerebral small vessel disease was associated with color reading ...
BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced that the European Commission has asked the Committee ...
New research connects mild acute kidney injury (AKI) with increased risks of dementia and cognitive impairment in older adults. Explore the implications for long-term cognitive health and care ...
Visiting friends, attending parties and going to church may help keep your brain healthy, according to research conducted at ...
BioArctic AB (publ) (NASDAQ STOCKHOLM: BIOA B) today announced that the U.S. Food and Drug Administration (FDA) has approved BioArctic's partner Eisai's ...
Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatmentAlzheimer's disease progression does ...
Global Alzheimer's Disease Therapeutics Market Size is expected to be worth around USD 30.8 Billion by 2033 from USD 5.5 Billion in 2023.
Emil Kraepelin formulated the initial nosology of Alzheimer's disease in the first decade of the 20th century. Nowadays, clinical and pathological presentations (including those associated with ...
Advances in critical care therapies for patients with cardiogenic shock (CS), including temporary mechanical circulatory support and multidisciplinary shock teams, have led to improved survival to ...